Holding(s) in Company

RNS Number : 0737P

AstraZeneca PLC

03 June 2015

 

For filings with the FCA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii				AstraZeneca plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights					X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii		The Capital Group Companies, Inc.
4. Full name of shareholder(s)  (if different from 3.):iv		See Schedule A
5. Date of the transaction and date on which the threshold is crossed or reached: v		1 June 2015
6. Date on which issuer notified:		2 June 2015
7. Threshold(s) that is/are crossed or reached: vi, vii		Below 3%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares (ISIN: GB0009895292)

31,704,772

31,704,772

30,437,552

2.4088%

ADRs (ISIN: US0463531089)

7,433,161

7,433,161

7,435,104

0.5884%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

37,872,656

2.9972%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
See Schedule A
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name:
15. Contact telephone number:

Note: Annex should only be submitted to the FCA not the issuer
Annex: Notification of major interests in share
A: Identity of the persons or legal entity subject to the notification obligation
Full name (including legal form of legal entities)	The Capital Group Companies, Inc.
Contact address (registered office for legal entities)	333 South Hope Street, 55th Floor Los Angeles, California 90071
Phone number & email	[phone] & [e-mail]
Other useful information (at least legal representative for legal persons)
B: Identity of the notifier, if applicable
Full name	Christopher Aquino
Contact address	333 South Hope Street, 55th Floor Los Angeles, California 90071
Phone number & email	[phone] & [e-mail]
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)	Fax: [phone]
C: Additional information
For notes on how to complete form TR-1 please see the FCA website.

Schedule A

As of 1 June 2015

AstraZeneca PLC

	Number of Shares	Percent of Outstanding
The Capital Group Companies, Inc. ("CG") holdings	37,872,656	2.997%
Holdings by CG Management Companies and Funds:
Capital Guardian Trust Company	5,512,014	0.436%
Capital International Limited	165,100	0.013%
Capital International Sàrl	154,992	0.012%
Capital International, Inc.	72,900	0.006%
Capital Research and Management Company	31,967,650	2.530%

 

END

 

 

HOLBGGDLXGGBGUX